Acceleration of mobile health for monitoring post‐transplant in the COVID‐19 era: Applications for pediatric settings. (18th October 2021)

• Record Type: Journal Article
• Authors: Campagna, Bianca R.; Tutino, Rebecca; Stevanovic, Kristina; Flood, Julia; Halevi, Gali; Shemesh, Eyal; Annunziato, Rachel A.
• Is Part Of: Pediatric transplantation. Volume 26:Number 1(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-10-18
• Subjects: mobile health -- monitoring -- pediatric transplantation -- telehealth; Transplantation of organs, tissues, etc. in children -- Periodicals; 617.95408305
• DOI: 10.1111/petr.14152
• Languages: English
• ISSNs: 1397-3142

Abstract

Abstract: Background: Since the start of the COVID‐19 pandemic and consequent lockdowns, the use of telehealth interventions has rapidly increased both in the general population and among transplant recipients. Among pediatric transplant recipients, this most frequently takes the form of interventions on mobile devices, or mHealth, such as remote visits via video chat or phone, phone‐based monitoring, and mobile apps. Telehealth interventions may offer the opportunity to provide care that minimizes many of the barriers of in‐person care. Methods: The present review followed the PRISMA guidelines. Sources up until October 2020 were initially identified through searches of PsycInfo ® and PubMed ® . Results: We identified ten papers that reported findings from adult interventions and five studies based in pediatrics. Eight of the adult publications stemmed from the same two trials; within the pediatric subset, this was the case for two papers. Studies that have looked at mHealth interventions have found high acceptability rates over the short run, but there is a general lack of data on long‐term use. Conclusions: The literature surrounding pediatric trials specifically is sparse with all findings referencing interventions that are in early stages of development, ranging from field tests to small feasibility trials. The lack of research highlights the need for a multi‐center RCT that utilizes robust measures of medication adherence and other outcome variables, with longer‐term follow‐up before telehealth interventions should be fully embraced.